Elsevier

Neurobiology of Disease

Volume 5, Issue 5, November 1998, Pages 305-322
Neurobiology of Disease

Regular Article
Disseminated Corticolimbic Neuronal Degeneration Induced in Rat Brain by MK-801: Potential Relevance to Alzheimer's Disease

https://doi.org/10.1006/nbdi.1998.0206Get rights and content

Abstract

Blockade ofN-methyl-d-aspartate (NMDA) glutamate receptors by MK-801 induces neuronal degeneration in the posterior cingulate/retrosplenial cortex and other corticolimbic regions although damage in the latter has not been adequately characterized. This disseminated corticolimbic damage is of interest since NMDA hypofunction, the mechanism that triggers this neurodegenerative syndrome, has been postulated to play a role in the pathophysiology of Alzheimer's disease (AD). Several histological methods, including electron microscopy, were used to evaluate the neurotoxic changes in various corticolimbic regions of rat brain following MK-801 or a combination of MK-801 plus pilocarpine. We found that MK-801 triggers neuronal degeneration in a widespread pattern similar to that induced by phencyclidine and that females showed more damage than males. The neurotoxic reaction involved additional brain regions when muscarinic receptors were hyperactivated by administering pilocarpine with MK-801. Ultrastructural evaluation revealed that a major feature of the neurotoxic action involves degeneration of dendritic spines which entails loss of synaptic complexes. The ultrastructural appearance of degenerating neurons was generally inconsistent with an apoptotic mechanism, although evidence equivocally consistent with apoptosis was observed in some instances. The cell death process evolved relatively slowly and was still ongoing 7 days posttreatment. Relevance of these results to AD is discussed.

References (42)

  • E.S. Matsuo et al.

    Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau

    Neuron

    (1994)
  • J.L. Price et al.

    The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

    Neurobiol. Aging

    (1991)
  • P. Saransaari et al.

    Dizocilpine binding to cerebral cortical membranes from developing and ageing mice

    Mech. Ageing Dev.

    (1995)
  • J. Ulas et al.

    Decreased expression ofNd

    Neuroscience

    (1997)
  • G.L. Wenk et al.

    Loss of NMDA, but not GABA-A, binding in the brains of aged rats and monkeys

    Neurobiol. Aging

    (1991)
  • A.H. Wyllie et al.

    Cell death: The significance of apoptosis

    Int. Rev. Cytol.

    (1980)
  • R. Auer

    Effect of age and sex onNd

    Stroke

    (1996)
  • C. Bolden et al.

    Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells

    J. Pharmacol. Exp. Ther.

    (1992)
  • S.T. Dekosky et al.

    Synapse loss in the frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

    Ann. Neurol.

    (1990)
  • J. de Olmos et al.

    Silver methods for the impregnation of degenerating axoplasm

    Neuroanatomical Tract-tracing Methods

    (1981)
  • Cited by (82)

    • Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms

      2017, Frontiers in Neuroendocrinology
      Citation Excerpt :

      Likewise, conflicting findings from postmortem studies has led to debate over whether gray matter loss reflects cell death or reduced neuropil and cell size (Schnieder and Dwork, 2011; Harrison, 1999). Animal studies employing NMDAR antagonists in both male and female rodents have had similarly inconclusive results, with some studies finding evidence of excitotoxicity and cell death (Ellison, 1994; Ellison and Switzer, 1993; Corso et al., 1997; Farber et al., 1995), and others finding cellular damage but no evidence of cell death (Genius et al., 2013; Wozniak et al., 1998). The conflicting results may stem from differences in dosage, length of treatment with NMDAR antagonists, and the length of recovery before analysis.

    • The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation

      2012, Behavioural Brain Research
      Citation Excerpt :

      The neuronal damage produced by NMDAR antagonists in the rat can be prevented by cholinergic or GABAergic drugs known to suppress the psychotomimetic properties of ketamine [43]. MK-801 triggered widespread neuronal damage in the rat brain, where females showed more damage than males [44]. The above studies indicate that either activation of the NMDAR with agonists such as NMDA [3,4], or deactivation of the receptor with antagonist drugs [41–44], can produce neurotoxicity.

    • Memantine prevents aluminum-induced cognitive deficit in rats

      2011, Behavioural Brain Research
      Citation Excerpt :

      The blockade of NMDA receptor-mediated excitotoxicity can help preserve neuronal structure and function [64–66]. The most significant problem being that at doses that exerted neuroprotective effects, NMDA antagonists caused adverse side effects ranging from memory dysfunction and psychotic reactions in humans [67–69] to acute injury and/or death of neurons in animal brain [70–72]. Memantine is rapidly displaced from the NMDA receptor, which may avoid prolonged receptor blockade and the detrimental effects on learning and memory associated with prolonged blockade of the NMDA receptor [64].

    • Esmethadone-HCl (REL-1017): a promising rapid antidepressant

      2023, European Archives of Psychiatry and Clinical Neuroscience
    View all citing articles on Scopus

    L. HeimerN. Robards

    1

    To whom correspondence should be addressed. Fax: (314) 362-2099. E-mail:[email protected].

    View full text